Sagittarius Life Science Corp. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 135.270 million compared to TWD 120.757 million a year ago. Operating loss was TWD 22.457 million compared to TWD 24.899 million a year ago. Net loss was TWD 23.587 million compared to TWD 20.378 million a year ago. Basic loss per share was TWD 0.72 compared to TWD 0.62 a year ago. For the half year, sales was TWD 284.112 million compared to TWD 216.609 million a year ago. Operating loss was TWD 37.491 million compared to TWD 50.913 million a year ago. Net loss was TWD 33.892 million compared to TWD 47.188 million a year ago. Basic loss per share was TWD 1.04 compared to TWD 1.44 a year ago.